Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Non-selectivity of ERG reductions in eyes treated for retinoblastoma.

Liu CY, Jonna G, Francis JH, Marr BP, Abramson DH, Brodie SE.

Doc Ophthalmol. 2014 Feb;128(1):13-23. doi: 10.1007/s10633-013-9416-8. Epub 2013 Nov 9.

PMID:
24213436
2.

Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.

Brodie SE, Pierre Gobin Y, Dunkel IJ, Kim JW, Abramson DH.

Doc Ophthalmol. 2009 Aug;119(1):13-22. doi: 10.1007/s10633-008-9164-3. Epub 2009 Jan 25.

PMID:
19169884
3.

Full-field electroretinogram in autism spectrum disorder.

Constable PA, Gaigg SB, Bowler DM, Jägle H, Thompson DA.

Doc Ophthalmol. 2016 Apr;132(2):83-99. doi: 10.1007/s10633-016-9529-y. Epub 2016 Feb 11.

PMID:
26868825
4.

ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma.

Brodie SE, Paulus YM, Patel M, Gobin YP, Dunkel IJ, Marr BP, Abramson DH.

Br J Ophthalmol. 2012 Jun;96(6):877-80. doi: 10.1136/bjophthalmol-2011-301248. Epub 2012 Mar 18.

PMID:
22426950
5.

Retinal on-pathway deficit in congenital disorder of glycosylation due to phosphomannomutase deficiency.

Thompson DA, Lyons RJ, Liasis A, Russell-Eggitt I, Jägle H, Grünewald S.

Arch Ophthalmol. 2012 Jun;130(6):712-9. doi: 10.1001/archophthalmol.2012.130.

PMID:
22801829
6.

Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.

Francis JH, Schaiquevich P, Buitrago E, Del Sole MJ, Zapata G, Croxatto JO, Marr BP, Brodie SE, Berra A, Chantada GL, Abramson DH.

Ophthalmology. 2014 Sep;121(9):1810-7. doi: 10.1016/j.ophtha.2014.03.028. Epub 2014 May 10.

PMID:
24819859
7.

Electroretinographic changes in the inner retinal layers of the retained eyes of patients with sporadic unilateral retinoblastoma.

Lubiński W, Zajaczek S, Sych Z, Penkala K, Palacz O, Lubiński J.

Ophthalmic Genet. 2002 Jun;23(2):99-107.

PMID:
12187428
8.

Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.

Francis JH, Brodie SE, Marr B, Zabor EC, Mondesire-Crump I, Abramson DH.

Ophthalmology. 2017 Apr;124(4):488-495. doi: 10.1016/j.ophtha.2016.12.015. Epub 2017 Jan 12.

PMID:
28089679
9.

[Evoked retinal and cortical potentials in children with advanced and resistant retinoblastoma after neoadjuvant polychemotherapy and superselective intra-arterial chemotherapy].

Zueva MV, Tsapenko IV, Saakian SV, Panteleeva OG, Zharua AA, Orlovskaia LS.

Vestn Oftalmol. 2014 Sep-Oct;130(5):22-9. Russian.

PMID:
25711058
10.

Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.

Francis JH, Abramson DH, Gobin YP, Marr BP, Tendler I, Brodie SE, Dunkel IJ.

Ophthalmology. 2015 May;122(5):1016-22. doi: 10.1016/j.ophtha.2014.11.029. Epub 2015 Jan 21.

11.

Full-field electroretinography under general anesthesia in retinoblastoma.

Sachidanandam R, Krishnakumar S, Gopal L, O'Brien JM, Khetan V, Sen P.

Doc Ophthalmol. 2013 Apr;126(2):149-57. doi: 10.1007/s10633-012-9368-4. Epub 2013 Jan 4.

PMID:
23288585
12.

Electrophysiological testing as a method of cone-rod and cone dystrophy diagnoses and prediction of disease progression.

Langwińska-Wośko E, Szulborski K, Zaleska-Żmijewska A, Szaflik J.

Doc Ophthalmol. 2015 Apr;130(2):103-9. doi: 10.1007/s10633-015-9479-9. Epub 2015 Jan 21.

PMID:
25603773
13.

Relative Genetic and Environmental Contributions to Variations in Human Retinal Electrical Responses Quantified in a Twin Study.

Bhatti T, Tariq A, Shen T, Williams KM, Hammond CJ, Mahroo OA.

Ophthalmology. 2017 Aug;124(8):1175-1185. doi: 10.1016/j.ophtha.2017.03.017. Epub 2017 Apr 20.

14.

Asymmetrical Functional Deficits of ON and OFF Retinal Processing in the mdx3Cv Mouse Model of Duchenne Muscular Dystrophy.

Tsai TI, Barboni MT, Nagy BV, Roux MJ, Rendon A, Ventura DF, Kremers J.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5788-5798. doi: 10.1167/iovs.16-19432.

PMID:
27792813
15.

Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function.

Abdelhakim AH, Francis JH, Marr BP, Gobin YP, Abramson DH, Brodie SE.

Br J Ophthalmol. 2017 May;101(5):623-628. doi: 10.1136/bjophthalmol-2016-308591. Epub 2016 Aug 18.

PMID:
27539090
16.

Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.

Abramson DH, Fabius AW, Francis JH, Marr BP, Dunkel IJ, Brodie SE, Escuder A, Gobin YP.

Ophthalmic Genet. 2017 Jan-Feb;38(1):16-21. doi: 10.1080/13816810.2016.1244695. Epub 2017 Jan 17.

17.

Characterizing the Retinal Function of Psammomys obesus: A Diurnal Rodent Model to Study Human Retinal Function.

Dellaa A, Polosa A, Mbarek S, Hammoum I, Messaoud R, Amara S, Azaiz R, Charfeddine R, Dogui M, Khairallah M, Lachapelle P, Ben Chaouacha-Chekir R.

Curr Eye Res. 2017 Jan;42(1):79-87. doi: 10.3109/02713683.2016.1141963. Epub 2016 May 23.

PMID:
27216715
18.

[Electrophysiological evaluation of retinal function after systemic and superselective intra-arterial chemotherapy for retinoblastoma].

Zueva MV, Saakyan SV, Zueva MV, Saakyan SV.

Vestn Oftalmol. 2015 Sep-Oct;131(5):111-114. doi: 10.17116/oftalma20151315111-114. Review. Russian.

PMID:
26845881
19.

Vigabatrin effect on inner retinal function.

Coupland SG, Zackon DH, Leonard BC, Ross TM.

Ophthalmology. 2001 Aug;108(8):1493-6; discussion 1497-8.

PMID:
11470707
20.

Electrophysiological findings show generalised post-photoreceptoral deficiency in macular telangiectasia type 2.

Ledolter AA, Holder GE, Ristl R, Schmidt-Erfurth U, Ritter M.

Br J Ophthalmol. 2018 Jan;102(1):114-119. doi: 10.1136/bjophthalmol-2017-310228. Epub 2017 Jun 7.

PMID:
28592417

Supplemental Content

Support Center